← Back to headlines
Novo Nordisk to Cut U.S. Prices for Ozempic and Wegovy
Novo Nordisk announced plans to reduce the U.S. list prices for its popular diabetes and weight-loss drugs, Ozempic and Wegovy, by up to 50%.
24 Feb, 19:19 — 24 Feb, 19:19
Sources
Showing 1 of 1 sources
